Annual report pursuant to Section 13 and 15(d)

Variable Interest Entity (Details)

v2.4.1.9
Variable Interest Entity (Details) (USD $)
12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2013
Concentration Risk [Line Items]      
Revenue $ 84,127,000us-gaap_SalesRevenueNet $ 102,073,000us-gaap_SalesRevenueNet $ 38,808,000us-gaap_SalesRevenueNet
Accounts receivable 11,845,000us-gaap_AccountsReceivableNetCurrent 15,831,000us-gaap_AccountsReceivableNetCurrent [1]  
Guarantor Obligations, Maximum Exposure, Undiscounted 700,000us-gaap_GuaranteeObligationsMaximumExposure    
AKA [Member]      
Concentration Risk [Line Items]      
Equity Method Investment, Ownership Percentage 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
   
Equity Method Investments 100,000us-gaap_EquityMethodInvestments
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
100,000us-gaap_EquityMethodInvestments
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
 
Revenue 1,700,000us-gaap_SalesRevenueNet
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
4,500,000us-gaap_SalesRevenueNet
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
 
Accounts receivable 400,000us-gaap_AccountsReceivableNetCurrent
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
400,000us-gaap_AccountsReceivableNetCurrent
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
 
Deferred Revenue $ 1,100,000us-gaap_DeferredRevenue
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
$ 1,000,000us-gaap_DeferredRevenue
/ us-gaap_ConcentrationRiskByTypeAxis
= wstl_AKAMember
 
[1] Certain amounts have been adjusted to reflect measurement period adjustments related to the CSI acquisition (see Note 2).